US Patent 10039757 C-Met modulator pharmaceutical compositions
Patent 10039757 was granted and assigned to Exelixis Ltd on August, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10039757 C-Met modulator pharmaceutical compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.